1. Market Research
  2. > Cancer Market Trends
  3. > Pancreatic Cancer Industry

Pancreatic Cancer Industry Statistics

You might be interested in: Therapy, Hospital, Mortality, Pharmaceutical, Infectious Disease, Cancer, Lung Cancer, Breast Cancer, Lymphoma, Colorectal Cancer, Ovarian Cancer, Prostate Cancer, Renal Cancer, Leukemia, Gastric Cancer, Bladder Cancer, Brain Cancer, Cervical Cancer, Endometrial Cancer, Skin Cancer.

1-7 of 39 reports for Pancreatic Cancer

Global Pancreatic Cancer Statistics - Forecast

  • September 2017
    3 pages
  • Pancreatic Canc...  

  • World  

    United States  

    Australia  

View report >

Cancer and Pancreatic Cancer Statistics in Australia and the US - Forecast

  • September 2017
    3 pages
  • Cancer  

    Pancreatic Canc...  

    Biopharmaceutic...  

View report >

Pancreatic Cancer Statistics in Japan and Europe

  • December 2017
    9 pages
  • Pancreatic Canc...  

  • Japan  

    Europe  

View report >

Pancreatic Cancer Statistics in China

  • January 2017
    15 pages
  • Pancreatic Canc...  

View report >

Pancreatic Cancer Statistics in the UK

  • February 2018
    14 pages
  • Pancreatic Canc...  

  • United Kingdom  

View report >

Pancreatic Cancer Statistics in Canada

  • April 2017
    9 pages
  • Pancreatic Canc...  

  • Canada  

    North America  

View report >

Pancreatic Cancer Statistics in Asia

  • January 2017
    13 pages
  • Pancreatic Canc...  

    Mortality  

  • Asia  

    World  

View report >
34 reports for Pancreatic Cancer

Purchase Reports From Reputable Market Research Publishers
(From $ 720 - $ 6250)

Drug Analysis: Masitinib

Drug Analysis: Masitinib

  • $ 10000
  • Industry report
  • January 2018
  • by Datamonitor Healthcare

Drug OverviewMasitinib (AB Science) is an oral tyrosine kinase inhibitor being developed by AB Science. It targets a number of receptor tyrosine kinases including c-Kit, fibroblast growth factor recepto ...


ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on